Nevirapine plus didanosine: once or twice daily combination?
van Heeswijk
R P
RP
Veldkamp
A I
AI
Mulder
J W
JW
Meenhorst
P L
PL
Wit
F W
FW
Reiss
P
P
Lange
J M
JM
Kwakkelstein
M O
MO
Beijnen
J H
JH
Hoetelmans
R M
RM
D000284:Administration, Oral; D000328:Adult; D019380:Anti-HIV Agents / Q000493:pharmacokinetics*; D016049:Didanosine / Q000493:pharmacokinetics*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D008297:Male; D019829:Nevirapine / Q000493:pharmacokinetics*
D019380:Anti-HIV Agents; D019829:Nevirapine; D016049:Didanosine